LEXARIA BIOSCIENCE CORP. Deferred Costs, Noncurrent
LEXARIA BIOSCIENCE CORP. (LEXX) had Deferred Costs, Noncurrent of $0 as of 2012-10-31, per its 10-K filed 2013-01-29.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredCosts · last filed 2013-01-29
- 2012-10-31: Deferred Costs, Noncurrent $0.00.
- 2012-07-31: Deferred Costs, Noncurrent $0.00.
- 2012-04-30: Deferred Costs, Noncurrent $48.87K.
- 2012-01-31: Deferred Costs, Noncurrent $48.87K.
| Period end | Deferred Costs, Noncurrent |
|---|---|
| 2012-10-31 | $0.00 10-K · filed 2013-01-29 |
| 2012-07-31 | $0.00 10-Q · filed 2012-09-12 |
| 2012-04-30 | $48.87K 10-Q · filed 2012-06-07 |
| 2012-01-31 | $48.87K 10-Q · filed 2012-03-13 |
| 2011-10-31 | $33.09K 10-K · filed 2013-01-29 |
| 2010-10-31 | $0.00 10-K · filed 2012-01-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |